Tromethamine

Tromethamine

SCHEMBL439905

C[Si](C)(C)OP(=O)(O)O.NC(CO)(CO)CO

nearest known ligand 0.42

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

DHFRGARTPTGFRPTGIRPTGS1PTGS2TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8envmurAthyA

The experimentally established mechanism targets of Tromethamine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.42
LMNA P02545 1/20 0.42
KMT2A Q03164 1/20 0.42
S1PR1 P21453 16/20 0.36
S1PR3 Q99500 16/20 0.36
S1PR4 O95977 3/20 0.33
S1PR5 Q9H228 3/20 0.33
S1PR2 O95136 2/20 0.33
SMPD1 P17405 2/20 0.32
FDPS P14324 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Tromethamine SCHEMBL22231513 0.82 MEN1 (0.37) MEN1LMNAKMT2AS1PR1S1PR3
Tromethamine SCHEMBL6421313 0.80 MEN1 (0.39) MEN1LMNAKMT2AS1PR1S1PR3
SCHEMBL437818 0.79
Tromethamine SCHEMBL31404437 0.78 MEN1 (0.50) MEN1LMNAKMT2AS1PR1S1PR3
Tromethamine SCHEMBL21111892 0.77 MEN1 (0.36) MEN1LMNAKMT2AS1PR1S1PR3
SCHEMBL28417042 0.77 FDPS (0.37) FDPS
Tromethamine SCHEMBL9425272 0.76 MEN1 (0.48) MEN1LMNAKMT2AS1PR1S1PR3
Tromethamine SCHEMBL7899122 0.74 LMNA (0.67) MEN1LMNAKMT2AS1PR1S1PR3
Tromethamine SCHEMBL1509014 0.74 LMNA (0.67) MEN1LMNAKMT2AS1PR1S1PR3
Tromethamine SCHEMBL11761781 0.72 MEN1 (0.43) MEN1LMNAKMT2AS1PR1S1PR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1765 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-122073261-A Electrolyte additive, electrolyte and battery 广州天赐高新材料股份有限公司 2026-05-22 CN claimed
CN-122051359-A Polymer electrolyte and contain this sodium ion battery of polymer electrolyte 浙江钠创新能源有限公司 2026-05-15 CN claimed
CN-122051388-A Electrolyte, lithium secondary battery, and method for forming lithium secondary battery 北京卫蓝新能源科技股份有限公司 2026-05-15 CN claimed
CN-122025807-A Secondary battery, battery module, battery pack, and power consumption device 宁德时代新能源科技股份有限公司 2026-05-12 CN claimed
US-20260112698-A1 Lithium Secondary Battery LG ENERGY SOLUTION, LTD. (KR) 2026-04-23 US claimed
CN-121583784-A Electrolyte capable of inhibiting decomposition of super capacitor binder, and preparation method and application thereof 今朝时代(安徽)新能源科技有限公司 2026-02-27 CN claimed
US-20250391917-A1 ELECTROLYTE, BATTERY, AND ELECTRIC DEVICE CONTEMPORARY AMPEREX TECHNOLOGY CO LTD (CN) 2025-12-25 US claimed
US-20250266446-A1 LITHIUM ION BATTERY SHENZHEN CAPCHEM TECHNOLOGY CO., LTD. (CN) 2025-08-21 US claimed
EP-4595143-A1 TERNARY SOLVENT ELECTROLYTES FOR HIGH VOLTAGE AND HIGH RATE LITHIUM BATTERIES Sepion Technologies, Inc. (US) 2025-08-06 EP claimed
CN-120199893-A Electrolyte additive composition, nonaqueous electrolyte containing same and secondary battery 深圳市研一新材料有限责任公司 2025-06-24 CN claimed
CN-110870126-A Electrolyte for lithium battery and lithium battery including the same 三星SDI株式会社 2020-03-06 CN claimed
CN-110854433-A Electrolyte and electrochemical device 欣旺达电动汽车电池有限公司 2020-02-28 CN claimed
CN-110746554-A Film forming agent and application thereof in semi-inorganic insulating coating liquid for silicon steel 常州广树化工科技有限公司 2020-02-04 CN claimed
US-10541138-B2 Diffusing agent composition and method of manufacturing semiconductor substrate TOKYO OHKA KOGYO CO., LTD. (JP) 2020-01-21 US claimed
CN-110707358-A Electrolyte for high-voltage lithium ion battery 中国科学院福建物质结构研究所 2020-01-17 CN claimed
CN-110627830-A Disodium p-nitrophenylphosphate and preparation method thereof 安徽昊帆生物有限公司 2019-12-31 CN claimed
US-20190043724-A1 DIFFUSING AGENT COMPOSITION AND METHOD OF MANUFACTURING SEMICONDUCTOR SUBSTRATE TOKYO OHKA KOGYO CO., LTD. (JP) 2019-02-07 US claimed
EP-1585142-A1 Composition for electrolyte, high molecular weight electrolyte, and battery using it SONY CORPORATION (JP) 2005-10-12 EP claimed
EP-1050916-A1 Phosphate additives for nonaqueous electrolyte in rechargeable electrochemical cells WILSON GREATBATCH LTD. (US) 2000-11-08 EP claimed
US-6093780-A CONSISTS OF ALPHA-CYANOACRYLATE AND A THERMAL RESISTANCE CONFERRING COMPONENT SELECTED FROM THE ALKYLATING AGENT SUCH AS 4-NITROBENZYL CHLORIDE OR POLYVINYL BENZYL CHLORIDE AND A SILYLATING AGENT LOCTITE CORPORATION (US) 2000-07-25 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260112698-A1 Lithium Secondary Battery SCN2B, KCNN2, KCNN3 MEN1 438/4885LMNA 1029/4885KMT2A 1125/4885
US-20250391917-A1 ELECTROLYTE, BATTERY, AND ELECTRIC DEVICE ATP5PO, CACNA2D3, SIK3 MEN1 4719/4885LMNA 3411/4885KMT2A 3655/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.